Valentini, Vincenzo
 Distribuzione geografica
Continente #
NA - Nord America 22.879
EU - Europa 20.047
AS - Asia 17.385
SA - Sud America 3.851
AF - Africa 588
OC - Oceania 84
Continente sconosciuto - Info sul continente non disponibili 36
Totale 64.870
Nazione #
US - Stati Uniti d'America 22.080
SG - Singapore 8.340
DE - Germania 6.185
CN - Cina 4.292
SE - Svezia 4.022
BR - Brasile 3.207
IT - Italia 2.355
UA - Ucraina 1.371
FR - Francia 1.297
IN - India 1.124
IE - Irlanda 1.040
GB - Regno Unito 937
VN - Vietnam 798
ID - Indonesia 701
FI - Finlandia 644
PL - Polonia 557
RU - Federazione Russa 491
CA - Canada 443
TR - Turchia 355
HK - Hong Kong 268
BD - Bangladesh 244
AR - Argentina 237
JP - Giappone 212
MX - Messico 212
BE - Belgio 199
IQ - Iraq 178
AT - Austria 173
NL - Olanda 164
ZA - Sudafrica 157
CZ - Repubblica Ceca 144
CI - Costa d'Avorio 134
ES - Italia 119
KR - Corea 102
PK - Pakistan 98
EC - Ecuador 93
IR - Iran 93
SA - Arabia Saudita 82
VE - Venezuela 71
MA - Marocco 68
AU - Australia 66
UZ - Uzbekistan 60
CO - Colombia 58
CH - Svizzera 56
CL - Cile 53
JO - Giordania 52
LT - Lituania 49
KE - Kenya 45
EG - Egitto 44
IL - Israele 44
PH - Filippine 44
PE - Perù 43
AE - Emirati Arabi Uniti 41
UY - Uruguay 35
TN - Tunisia 33
JM - Giamaica 32
AZ - Azerbaigian 31
PY - Paraguay 30
RO - Romania 30
KZ - Kazakistan 29
DZ - Algeria 24
AL - Albania 22
EU - Europa 22
PT - Portogallo 22
BO - Bolivia 20
NP - Nepal 20
PA - Panama 20
NO - Norvegia 19
OM - Oman 19
GR - Grecia 18
MY - Malesia 18
RS - Serbia 17
HN - Honduras 16
NZ - Nuova Zelanda 16
BG - Bulgaria 15
DK - Danimarca 15
DO - Repubblica Dominicana 15
SN - Senegal 15
AM - Armenia 14
KG - Kirghizistan 14
LK - Sri Lanka 14
CR - Costa Rica 13
TT - Trinidad e Tobago 13
BH - Bahrain 11
ET - Etiopia 11
LV - Lettonia 11
TH - Thailandia 11
A2 - ???statistics.table.value.countryCode.A2??? 10
LB - Libano 10
LU - Lussemburgo 10
NG - Nigeria 10
SK - Slovacchia (Repubblica Slovacca) 10
BY - Bielorussia 9
QA - Qatar 9
GE - Georgia 8
HR - Croazia 8
KW - Kuwait 8
MD - Moldavia 8
PS - Palestinian Territory 8
TW - Taiwan 8
AO - Angola 7
Totale 64.730
Città #
Chandler 4.006
Singapore 3.921
Ashburn 2.196
Dublin 1.033
Beijing 978
Jacksonville 824
New York 816
San Mateo 758
Ann Arbor 634
Los Angeles 628
Jakarta 627
Wilmington 521
Nanjing 510
Milan 490
Warsaw 475
Munich 434
Frankfurt am Main 409
Boston 405
Woodbridge 377
Rome 374
The Dalles 363
Hyderabad 359
Hefei 353
Dearborn 348
Houston 310
São Paulo 299
Princeton 292
Moscow 289
Nürnberg 285
Fairfield 271
Ho Chi Minh City 266
Marseille 263
Lawrence 247
Bremen 244
Hong Kong 244
Helsinki 233
Cattolica 232
Chicago 230
Izmir 219
Hanoi 213
Dallas 211
Seattle 211
Redwood City 200
Brussels 195
Nanchang 176
Buffalo 166
Zhengzhou 158
Toronto 141
Tokyo 140
Abidjan 134
Boardman 130
London 121
Santa Clara 119
Brooklyn 109
Nuremberg 108
Vienna 104
Montreal 96
Turku 94
Shenyang 92
Leawood 91
Seoul 91
Johannesburg 86
Kunming 86
Kent 84
Augusta 83
Tianjin 83
Norwalk 82
Rio de Janeiro 81
Orem 80
Pune 79
Shanghai 78
Düsseldorf 77
Phoenix 76
Stockholm 76
Denver 74
Jiaxing 74
Atlanta 73
Hebei 73
Washington 72
Cambridge 71
Detroit 70
Belo Horizonte 69
Brno 68
Mountain View 68
University Park 66
Changsha 65
San Francisco 65
Fremont 63
Hangzhou 63
Guangzhou 60
North Bergen 59
Poplar 59
Curitiba 57
Chennai 56
Lauterbourg 56
Amsterdam 55
Dhaka 55
Lappeenranta 55
Ottawa 55
Mexico City 54
Totale 31.569
Nome #
Clinical outcome of recurrent locally advanced cervical cancer (lacc) submitted to primary multimodality therapies 835
Chemoradiation with concomitant boosts followed by radical surgery in locally advanced cervical cancer: long-term results of the ROMA-2 prospective phase 2 study 348
Low-dose fractionated radiotherapy and concomitant chemotherapy in glioblastoma multiforme with poor prognosis: a feasibility study 293
Neoadjuvant Concurrent Radiochemotherapy in Locally Advanced (IIIa-IIIb) Non-Small Cell Lung Cancer: long term results according to downstaging. 289
Results of a phase II study of Short-course Accelerated Radiation Therapy (SHARON) for multiple brain metastases 286
The role of radiotherapy (RT) in the treatment of Adenoid Cystic Carcinoma of the Breast: case report of RT retreatment and literature review 277
EP-1325 Personalized Medicine in breast cancer: a nomogram from prognostic score to deescalate radiotherapy 269
A digital solution to support the activities: Multidisciplinary Tumor Board process and impact analysis 257
EP-1181: Prostheses irradiation in breast cancer: clinical and aesthetic outcomes in retrospective series 248
Diffusion-Weighted Magnetic Resonance Imaging in Monitoring Rectal Cancer Response to Neoadjuvant Chemoradiotherapy. 247
Low-dose radiotherapy as a chemo-potentiator of a chemotherapy regimen with pemetrexed for recurrent non-small-cell lung cancer: a prospective phase II study. 247
Does restaging MRI radiomics analysis improve pathological complete response prediction in rectal cancer patients? A prognostic model development 244
Can Elderly Patients With Newly Diagnosed Glioblastoma be Enrolled in Radiochemotherapy Trials? 239
Multidisciplinary approach in the treatment of T1 glottic cancer. The role of patient preference in a homogenous patient population 232
Rectal cancer multidisciplinary treatment: evidences, consensus and perspectives. 227
Endoscopy-guided brachytherapy for sinonasal and nasopharyngeal recurrences 210
Intensified adjuvant treatment of prostate carcinoma: feasibility analysis of a phase I/II trial 210
Mammography before post-operative radiotherapy in conservatively managed breast cancer patients: is it useful? 209
Translational Research in the Era of Precision Medicine: Where We Are and Where We Will Go 208
Automatic delineation for replanning in nasopharynx radiotherapy: what is the agreement among experts to be considered as benchmark? 206
Impact of age and co-morbidities in patients with newly diagnosed glioblastoma: a pooled data analysis of three prospective mono-institutional phase II studies 205
Diagnosis and treatment of bone metastases in breast cancer: Radiotherapy, local approach and systemic therapy in a guide for clinicians 200
Comparison of interstitial brachytherapy and surgery as primary treatments for nasal vestibule carcinomas 199
A machine-learning parsimonious multivariable predictive model of mortality risk in patients with Covid-19 199
Prognostic implications of the lymph node count after neoadjuvant treatment for rectal cancer 196
Medicine is a science of uncertainty and an art of probability (Sir W. Osler) 196
Infusional 5-fluorouracil and ZD1839 (Gefitinib-Iressa) in combination with preoperative radiotherapy in patients with locally advanced rectal cancer: a phase I and II Trial (1839IL/0092) 194
Short-Course Accelerated Radiotherapy in Palliative Treatment of Advanced Pelvic Malignancies: A Phase I Study 193
Adjuvant radiotherapy in non small cell lung cancer with pathological stage I: definitive results of a phase III randomized trial. 192
Personalized Clinical Phenotyping through Systems Medicine and Artificial Intelligence 190
Radioprotective effect of moderate wine consumption in patients with breast carcinoma. 187
Reducing heart dose during left breast cancer radiotherapy: comparison among 3 radiation techniques 187
Single-arm phase II study of conformal radiation therapy and temozolomide plus fractionated stereotactic conformal boost in high-grade gliomas: final report. 184
 ¹⁸F-FDG PET-CT during chemo-radiotherapy in patients with non-small cell lung cancer: the early metabolic response correlates with the delivered radiation dose. 184
Whole-brain radiotherapy combined with surgery or stereotactic radiotherapy in patients with brain oligometastases: long-term analysis. 183
Chemoradiation with concomitant boosts followed by radical surgery in locally advanced cervical cancer: long-term results of the ROMA-2 prospective phase 2 study 183
Human papillomavirus (HPV) infection in squamous cell carcinomas arising from the oropharynx: detection of HPV DNA and p16 immunohistochemistry as diagnostic and prognostic indicators--a pilot study 181
Chemoradiation and brachytherapy in biliary tract carcinoma - Long-term results 180
A feasibility study of neo-adjuvant low-dose fractionated radiotherapy with two different concurrent anthracycline-docetaxel schedules in stage IIA/B-IIIA breast cancer 177
Planning comparison between standard and conformal 3D techniques in post-operative radiotherapy of gastric cancer: a systematic review 177
Chemoradiation and brachytherapy in extrahepatic bile duct carcinoma 175
Nomograms for predicting local recurrence, distant metastases, and overall survival for patients with locally advanced rectal cancer on the basis of European randomized clinical trials. 174
Concurrent and adjuvant temozolomide-based chemoradiotherapy schedules for glioblastoma. Hypotheses based on two prospective phase II trials 173
Outcomes of clinical T4M0 extra-peritoneal rectal cancer treated with preoperative radiochemtoherapy and surgery. A prospective evalation of a single institutional experience. 172
Oncotype DX Predictive Nomogram for Recurrence Score Output: The Novel System ADAPTED01 Based on Quantitative Immunochemistry Analysis 172
Development of a digital research assistant for the management of patients’ enrollment in oncology clinical trials within a research hospital 172
Radiosurgery or Fractionated Stereotactic Radiotherapy plus Whole-brain Radioherapy in Brain Oligometastases: A Long-term Analysis 171
Locally advanced rectal cancer: MR imaging in prediction of response after preoperative chemoterapy and radioation therapy 170
A systematic review of resectability and survival after concurrent chemoradiation in primarily unresectable pancreatic cancer. 170
Outcomes of clinical t4m0 extra-peritoneal rectal cancer treated with preoperative radiochemotherapy and surgery: a prospective evaluation of a single institutional experience. 170
Is two-dimensional field definition sufficient for pelvic node coverage in rectal cancer compared to technical three-dimensional definition? 170
Intraluminal brachytherapy without stenting in intrahepatic papillary cholangiocarcinoma: a case report 169
Impact of Radiotherapy on Pain Relief and Recalcification in Plasma Cell Neoplasms : Long-Term Experience. 169
Phase I-II studies on accelerated IMRT in breast carcinoma: technical comparison and acute toxicity in 332 patients. 169
Long-term Analysis of Gemcitabine-based Chemoradiation after Surgical Resection for Pancreatic Adenocarcinoma 169
Capecitabine based postoperative accelerated chemoradiation of pancreatic carcinoma. A dose-escalation study. 168
Oncological outcome in advanced laryngeal cancers treated with different modalities in a single institution. A retrospective analysis on 65 cases. 167
Clinical validation of atlas-based auto-segmentation of pelvic volumes and normal tissue in rectal tumors using auto-segmentation computed system 167
Experimental evaluation of the impact of low tesla transverse magnetic field on dose distribution in presence of tissue interfaces 167
Evaluation of early regression index as response predictor in cervical cancer: A retrospective study on T2 and DWI MR images 166
Clinical target volume delineation including elective nodal irradiation in preoperative and definitive radiotherapy of pancreatic cancer 166
Evidence and research perspectives for surgeons in the European Rectal Cancer Consensus Conference (EURECA-CC2). 164
Quality of life and toxicity of stereotactic radiotherapy in pancreatic tumors: a case series 164
Long-term analysis of gemcitabine-based chemoradiation after surgical resection for pancreatic adenocarcinoma 164
Diffusion-weighted magnetic resonance imaging in monitoring rectal cancer response to neoadjuvant chemoradiotherapy 162
Locally advanced rectal cancer: MR imaging in prediction of response after preoperative chemotherapy and radiation therapy. 162
Oncological outcome of hypopharyngeal carcinoma treated with different modalities at two different university hospitals 162
International consensus guidelines on Clinical Target Volume delineation in rectal cancer 162
Postoperative intensity modulated radiation therapy in high risk prostate cancer: A dosimetric comparison. 161
Transanal endoscopic microsurgery after neoadjuvant radiochemotherapy for locally advanced extraperitoneal rectal cancer: short-term morbidity and functional outcome. 160
Low-dose fractionated radiotherapy and concomitant chemotherapy for recurrent or progressive glioblastoma: final report of a pilot study 160
External beam radiotherapy plus 24 hours continuous infusion of gemcitabine in unresectable pancreatic carcinoma: long term result of a phase II study 159
A real-time integrated framework to support clinical decision making for covid-19 patients 159
The predictive value of 18F-FDG PET/CT for assessing pathological response and survival in locally advanced rectal cancer after neoadjuvant radiochemotherapy 158
Lung abnormalities at multimodality imaging after radiation therapy for non-small cell lung cancer 157
Early radiation-induced mucosal changes evaluated by proctoscopy: Predictive role of dosimetric parameters 157
A phase I study of short-course accelerated whole brain radiation therapy for multiple brain metastases 157
Accelerated intensity-modulated radiotherapy plus temozolomide in patients with glioblastoma: a phase I dose-escalation study (ISIDE-BT-1) 157
The impact of the multidisciplinary tumor board (MDTB) on the management of pancreatic diseases in a tertiary referral center 157
Concomitant boost radiotherapy and multidrug chemotherapy in the neoadjuvant treatment of locally advanced rectal cancer: results of a phase II study 155
Patients’ Satisfaction by SmileInTM Totems in Radiotherapy: A Two-Year Mono-Institutional Experience 155
Intraoperative radiation therapy in resected pancreatic carcinoma: long-term analysis. 154
Multiple abscesses in a patient treated with cetuximab 153
Stereotactic radiosurgery (SRS) with volumetric modulated arc therapy (VMAT): interim results of a multi-arm phase I trial (DESTROY-2) 152
Endoscopy-guided brachytherapy for sinonasal and nasopharyngeal recurrences 152
Volumetric intensity modulated arc therapy for stereotactic body radiosurgery in oligometastatic breast and gynecological cancers: feasibility and clinical results 151
Vaccines and Myocardial Injury in Patients Hospitalized for COVID-19 Infection: the CardioCOVID-Gemelli Study 150
Adjuvant chemoradiotherapy in gastric cancer: a pooled analysis of the AIRO gastrointestinal group experience 150
Impact of radiotherapy on pain relief and recalcification in plasma cell neoplasms: long-term experience 149
Early proctoscopy is a surrogate endpoint of late rectal toxicity in prostate cancer treated with radiotherapy 148
Extracranial radiosurgery with volumetric modulated arc therapy: Feasibility evaluation of a phase I trial 148
Preoperative Chemoradiation With VMAT-SIB in Rectal Cancer: A Phase II Study 148
Exploring technical issues in personalized medicine: NSCLC survival prediction by quantitative image analysis-usefulness of density correction of volumetric CT data 147
THUNDER 2: THeragnostic Utilities for Neoplastic DisEases of the Rectum by MRI guided radiotherapy 147
Forward planned intensity modulated radiotherapy (IMRT) for whole breast postoperative radiotherapy. Is it useful? When? 146
Adjuvant volumetric-modulated arc therapy with simultaneous integrated boost in endometrial cancer. Planning and toxicity comparison 146
Postoperative intensity modulated radiation therapy in high risk prostate cancer: a dosimetric comparison 145
Can "early" and "late"18F-FDG PET-CT be used as prognostic factors for the clinical outcome of patients with locally advanced head and neck cancer treated with radio-chemotherapy? 145
Hypofractionated intensity-modulated radiotherapy with simultaneous integrated boost after radical prostatectomy: preliminary results of a phase II trial 145
Radiotherapy and concurrent metronomic chemotherapy in hormone-refractory prostate carcinoma: a Phase I study 145
Totale 18.947
Categoria #
all - tutte 291.636
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 291.636


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.812 0 0 0 0 0 151 341 79 370 213 547 111
2021/20225.268 516 307 103 411 252 171 80 723 232 348 1.135 990
2022/202311.225 1.570 1.538 869 1.747 675 1.314 566 874 1.249 240 412 171
2023/20245.589 231 1.532 225 369 241 860 325 299 80 195 581 651
2024/202511.732 313 362 890 433 1.125 419 416 538 1.695 1.282 2.297 1.962
2025/202616.299 4.464 806 1.542 3.207 5.124 1.156 0 0 0 0 0 0
Totale 66.087